Compare ALLO & EBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | EBF |
|---|---|---|
| Founded | 2017 | 1909 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Office Equipment/Supplies/Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 597.7M | 538.9M |
| IPO Year | 2018 | 1994 |
| Metric | ALLO | EBF |
|---|---|---|
| Price | $1.69 | $21.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $8.35 | N/A |
| AVG Volume (30 Days) | ★ 4.8M | 125.1K |
| Earning Date | 05-07-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 4.85% |
| EPS Growth | ★ 34.09 | 7.79 |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.96 |
| Revenue Next Year | $142,416.42 | N/A |
| P/E Ratio | ★ N/A | $54.85 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.04 | $16.30 |
| 52 Week High | $4.46 | $22.94 |
| Indicator | ALLO | EBF |
|---|---|---|
| Relative Strength Index (RSI) | 35.42 | 42.93 |
| Support Level | $1.59 | $20.81 |
| Resistance Level | $1.92 | $21.52 |
| Average True Range (ATR) | 0.08 | 0.35 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 6.58 | 52.29 |
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
Ennis Inc is a trade printer company that manufactures a broad range of printed products throughout the United States. It is engaged in the business of manufacturing, designing, and selling business forms and other printed business products to distributors located in the United States. Through a network of independent distributors, its channel encompasses independent print distributors, commercial printers, direct mail, fulfillment companies, payroll and accounts payable software companies, and advertising agencies, among others. The group operates in a single reportable segment called Print and derives its operating revenues from the manufacturing of mostly custom or semi-custom printed products sold mostly to independent distributors in the United States.